Why Health Funding Misses the Big Picture

Rich health systems use a tool called health technology assessment to decide what treatments to pay for. This tool measures how much a new drug or device helps the patient who gets it. It does a careful job on that narrow question. But it often skips the bigger picture of community health.

Experts say there are three ways to judge value. One looks at clinical benefit for the individual. Another calculates cost per unit of health gained. A third considers population health things like how common a disease is, prevention, how illness spreads, fairness between groups, and what the public actually wants. The first two methods run the show. The third gets mentioned but never becomes the standard for big agencies.

Important factors get left out of the final math. How many people suffer from a condition? Can we stop it before it starts? Does a vaccine protect others too? Are some groups getting left behind? What priorities did voters choose? These points show up in documents but they rarely change the final funding decision.

The gap is not an accident. It is built into the current design. The system asks how much does this help one person and how cheap is it per health unit. It seldom asks how do we improve health for everyone in a fair way. The tools to fix this already exist and they fit with existing budgets. Common objections like saying current metrics already capture population value or that setting priorities equals political meddling do not hold up under scrutiny.

A better approach would add explicit disease burden checks, transmission models, transparent priority setting, and formal equity analysis. This could line up funding decisions with what actually makes populations healthier. Leaders from EUPHA and HTAi are being asked to form a joint working group to make this happen.